Staged carotid angioplasty and stenting followed by cardiac surgery in @entity1 with severe asymptomatic XXXX : early and long-term results.

@entity1 @entity8 @entity64 @entity583 @entity1030 @entity16 @entity2998 @entity299 @entity453 @entity543 @entity204
BACKGROUND: The strategy for treating @entity1 with severe asymptomatic @entity543 and @entity299 remains unresolved. Staged or combined carotid endarterectomy in these @entity1 offers the potential benefit of decreased @entity16 during and after cardiac surgery; however, in high-risk @entity1 with severe @entity453 , @entity1030 , or @entity8 , the incidence of @entity204 and @entity64 is significantly higher. METHODS AND RESULTS: We report the results of a prospective, single-center study designed to evaluate the feasibility and safety of @entity2998 ( @entity2998 ) before cardiac surgery in neurologically asymptomatic @entity1 . The periprocedural and long-term outcomes of 356 consecutive @entity1 who underwent @entity2998 before cardiac surgery were analyzed. The procedural success rate of @entity2998 was 97.7%. The @entity204 and @entity64 rate from time of @entity2998 to 30 days after cardiac surgery was 4.8% (n=17). The @entity583 rate from time of @entity2998 to 30 days after cardiac surgery was 2.0% (n=7), and the combined @entity204 , @entity64 , and @entity583 rate was 6.7% (n=24). Distal embolic protection devices were used in 40% of the cases. CONCLUSIONS: This large cohort of asymptomatic @entity1 who underwent staged @entity2998 and cardiac surgery experienced a low periprocedural complication rate. The high rate of freedom from @entity204 and @entity64 during the 5 years of follow-up supports the long-term durability of this approach. Our findings suggest that this new strategy may become a valuable alternative in the treatment of @entity1 with combined carotid and @entity299 .
